Adams Diversified Equity Fund’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-72,300
Closed -$5.78M 95
2025
Q3
$5.78M Sell
72,300
-16,900
-19% -$1.44M 0.19% 91
2025
Q2
$8.11M Hold
89,200
0.29% 90
2025
Q1
$8.36M Sell
89,200
-97,500
-52% -$8.73M 0.33% 87
2024
Q4
$17M Sell
186,700
-8,300
-4% -$792K 0.64% 53
2024
Q3
$20.2M Sell
195,000
-77,600
-28% -$7.91M 0.74% 43
2024
Q2
$26.5M Buy
272,600
+17,400
+7% +$1.61M 0.9% 30
2024
Q1
$23M Buy
255,200
+64,400
+34% +$5.46M 0.82% 49
2023
Q4
$15.2M Buy
190,800
+32,300
+20% +$2.43M 0.6% 61
2023
Q3
$11.3M Hold
158,500
0.48% 77
2023
Q2
$12.2M Buy
+158,500
New +$12.3M 0.51% 80
2018
Q1
Sell
-156,600
Closed -$11.8M 217
2017
Q4
$11.8M Buy
+156,600
New +$11.4M 0.64% 61

Other funds holding CL

Adams Diversified Equity Fund's CL Position: Q4 2025 in Review

Adams Diversified Equity Fund sold out of Colgate-Palmolive (CL) in Q4 2025, closing a stake of 72,300 shares — an estimated $5.78M sold.

Adams Diversified Equity Fund first reported a position in CL in Q4 2017 and held it in 11 quarters. The position peaked at $26.5M in Q2 2024. 1,892 funds tracked by Wall St. Rank hold CL as of Q4 2025.

  • Adams Diversified Equity Fund reported no remaining Colgate-Palmolive position as of Q4 2025 after selling out during the quarter.
  • Adams Diversified Equity Fund sold 72,300 Colgate-Palmolive shares in Q4 2025, an estimated $5.78M.
  • Adams Diversified Equity Fund first reported a position in Colgate-Palmolive in Q4 2017 and held it in 11 quarters.
  • Adams Diversified Equity Fund's Colgate-Palmolive position peaked at $26.5M in Q2 2024.
  • 1,892 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2025.

Based on Adams Diversified Equity Fund's 13F filing for Q4 2025, filed 13 Feb 2026.